Related Experiment Video
Updated: Oct 4, 2026

A Surgical Method for Subvalvular Structure Intervention Through a Transaortic Approach in Normal Bama Pigs
Published on: March 13, 2026
Pressure-guided nonsurgical myocardial reduction induced by small septal infarctions in hypertrophic obstructive
P Boekstegers1, P Steinbigler, A Molnar
1Internal Medicine I, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany. boekstegers@med1.med.uni-muenchen.de
Insights
Pressure-guided nonsurgical myocardial reduction (NSMR) effectively reduces left ventricular outflow tract obstruction in hypertrophic obstructive cardiomyopathy (HOCM) patients. This safe procedure improves symptoms and quality of life by inducing small septal infarctions.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Hypertrophic obstructive cardiomyopathy (HOCM) is characterized by left ventricular outflow tract (LVOT) obstruction.
- Nonsurgical myocardial reduction (NSMR) aims to alleviate LVOT obstruction and improve patient symptoms.
- Previous NSMR studies show variable infarct sizes, impacting outcomes.
Purpose of the Study:
- To evaluate the safety and efficacy of pressure-guided NSMR in HOCM patients.
- To assess the impact of inducing small septal infarctions on LVOT obstruction and symptoms.
Main Methods:
- Fifty HOCM patients underwent pressure-guided NSMR.
- LVOT gradients were measured invasively pre-intervention and at 4-6 and 12-18 months post-NSMR.
- Patient-reported outcomes (NYHA class, quality of life) and exercise capacity were assessed.
Main Results:
- Small septal infarctions led to a sustained reduction in LVOT gradients from 80 mmHg to 17-18 mmHg (p < 0.001).
- NSMR was associated with decreased LV hypertrophy and improved exercise capacity.
- Quality of life significantly improved post-procedure.
Conclusions:
- Pressure-guided NSMR with small septal infarctions effectively reduces LVOT obstruction and improves HOCM symptoms.
- Minimizing infarct size may reduce complication rates, such as complete heart block requiring permanent pacemaker implantation.
Objectives:
We sought to assess the safety and efficacy of pressure-guided nonsurgical myocardial reduction (NSMR) with the induction of small septal infarctions in patients with hypertrophic obstructive cardiomyopathy (HOCM).
Background:
Nonsurgical myocardial reduction has been shown to decrease left ventricular outflow tract (LVOT) obstruction and to improve symptoms in patients with HOCM. Infarct sizes differ considerably among studies published so far.
Methods:
In 50 patients, the LVOT gradient was invasively determined at the time of the intervention, four to six months (n = 49) and 12 to 18 months (n = 25) after NSMR. New York Heart Association functional class and quality of life were assessed by using a standard questionnaire. Exercise capacity was tested by spiro-ergometry. Left ventricular (LV) mass was determined by electron beam computed tomography.
Results:
Small septal infarctions (mean creatine kinase value 413 +/- 193 U/l) resulted in a sustained decrease in LVOT gradients, from 80 +/- 33 to 18 +/- 17 mm Hg after four to six months (p < 0.001, n = 49) and to 17 +/- 15 mm Hg (p < 0.001, n = 25) after 12 to 18 months. Nonsurgical myocardial reduction was followed by a decrease in LV hypertrophy, which was associated with a sustained increase in exercise capacity, as well as improvement in quality of life.
Conclusions:
Pressure-guided NSMR inducing small septal infarctions was sufficient to result in a sustained decrease in LVOT obstruction and to improve symptoms. The incidence of complications, such as complete heart block with necessary permanent pacemaker implantation (<10%), seems to be diminished by minimizing the infarct size.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Myocarditis III: Medical Management
Mitral Stenosis III: Medical Management

